
The Federal Trade Commission plans to file an injunction on Monday to prevent Microsoft’s proposed acquisition of Activision Blizzard.
Reuters reported that the FTC has filed for an injunction to halt the transaction before the July 18 deadline.
The FTC filed a lawsuit to prevent the $68.7 billion acquisition and opted to present the case to its internal administrative law judge. The judge’s initial decision could be challenged and brought to the full commission for a final vote.
After that, Microsoft could appeal to a federal court should the decision not go its way. The case is set to go before the administrative law judge in August.
Read more: Microsoft Drops Claim Against US FTC In Activision Blizzard Case
An appeal of the U.K.’s Competition and Markets Authority’s decision to block the merger is also scheduled to take place this summer shortly after the acquisition deadline.
“We welcome the opportunity to present our case in federal court,” Microsoft President Brad Smith said. “We believe accelerating the legal process in the U.S will ultimately bring more choice and competition to the market.”
Microsoft has stated that their proposed deal would have positive effects on both gamers and gaming companies. They have committed to signing a legally binding consent decree with the FTC, which would include providing access to “Call of Duty” games to competitors like Sony for a period of ten years.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas